跳至主要内容
临床试验/ISRCTN10404684
ISRCTN10404684已完成4 期

Efficacy and tolerability of a topical formulation based on growth factors, caffeine and taurine in male subjects with androgenetic alopecia who are candidates for pharmacological treatments (topical minoxidil or oral finasteride): A prospective, randomized, assessor-blinded, parallel group study.

Difa Cooper (Italy)0 个研究点目标入组 60 人开始时间: 2022年7月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

2022 Results article in https://doi.org/10.29011/2575-8268.100199 (added 31/05/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Men and women >18 years of age
  • 2. Suffering AGA or FAGA requiring drugs treatments (Norwood Hamilton AGA grade III-V)

排除标准

  • 1. Inflammatory scalp skin condition
  • 2. AGA treatments (finasteride or minoxidil) in the previous 6 months
  • 3. Iron deficiency anaemia
  • 4. Seborrheic dermatitis or scalp psoriasis

研究者

发起方
Difa Cooper (Italy)

相似试验